Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090853 | SCV001246611 | pathogenic | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001090853 | SCV001762120 | pathogenic | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001090853 | SCV002126099 | pathogenic | not provided | 2022-08-17 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 105). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with PCARE-related conditions (PMID: 20398884, 28763557). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys919Thrfs*2) in the PCARE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCARE are known to be pathogenic (PMID: 20398886, 24339724, 26496393). |
Institute of Human Genetics, |
RCV004814785 | SCV005069679 | pathogenic | Retinal dystrophy | 2021-01-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000125 | SCV000020268 | pathogenic | Retinitis pigmentosa 54 | 2010-05-14 | no assertion criteria provided | literature only | |
Sharon lab, |
RCV001002902 | SCV001160937 | pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research | |
Faculty of Health Sciences, |
RCV001257874 | SCV001434625 | pathogenic | Autosomal recessive retinitis pigmentosa | 2017-08-01 | no assertion criteria provided | literature only |